Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Impact of Mental Health First Aid-trained Peers on the Mental Well-being of First-year Medical Residents.

NCT07161284 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-11-21
Last updated
2025-12-30

Condition(s) studied

Mental Well-being

Investigational drug(s) / intervention(s)

Exposition to trained peer-support registrars for a year

Exposition to trained peer-support registrars for a year: Exposition to trained peer-support registrars for a year

Study summary

Medical students, especially those in postgraduate training, face a complex array of challenges such as fatigue; work-life balance conflicts; difficulties managing dual hierarchies (hospital and university). Surprisingly, residents receive little to no dedicated training in recognizing and managing psychiatric disorders, except for psychiatry residents. This gap is exacerbated by persistent stigma towards psychiatric conditions. The Mental Health First Aid (MHFA) training approach could offer an innovative solution, addressing the root of the problem. This prospective, single-center cohort study aims to compare (1) the mental well-being of first-year specialty residents in the Lyon subdivision exposed to MHFA-trained peers; with (2) the mental well-being of unexposed second-year specialty residents. The hypothesis is that exposure to peers trained in MHFA improves well-being and reduces symptoms of burnout, depression, and anxiety at 3, 6, 9, and 12 months among peer residents.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * subject to the non-opposition of the residents, all medical residents entering their first and second year of specialized studies (DES) on November 1, 2025, in the city of Lyon will be included in the study. Exclusion Criteria: * refusal to participate AND in the unlikely cases where: * subject under guardianship or curatorship; * subject unable to give free and informed consent; * subject under legal protection

Primary outcome measure(s)

  • Well-being — Measured at Month 12
    As measured by the total score on the WEMWBS (Warwick-Edinburgh Mental Well-being Scale), a self-questionnaire. 5 point Likert scale (1-4); 14 questions

Trial sites (1)

FacilityCityRegionStatus
Service des Urgences Psychiatriques Hôpital Edouard Herriot, GH Centre Lyon France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07161284 on ClinicalTrials.gov ↗ ← All trials in France